Home / Resource Library / Anti-Spike T-cell and Antibody Responses to SARS-CoV-2 mRNA Vaccines in Patients with Hematologic MalignanciesAnti-Spike T-cell and Antibody Responses to SARS-CoV-2 mRNA Vaccines in Patients with Hematologic Malignancies